NR4A2 and Parkinson disease: The results of behavioral tests, analysis of tissue sections, and gene expression in the present study, showed that transplantation of P19 cells transfected with pCMV3-C-NR4A2-GFPSpark vector, to the model of Parkinson’s rats, could partially mitigate the disease symptoms.